Dashboard
Manage Tickers

PFEPFIZER INC

NYSE pfizer.com


$ 30.42 $ -0.23 (-0.75 %)    

Friday, 02-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 448.50 $ -3.34 (-0.74 %)
DIA $ 397.31 $ -5.92 (-1.47 %)
SPY $ 532.92 $ -10.09 (-1.86 %)
TLT $ 98.17 $ 2.86 (3 %)
GLD $ 225.36 $ -0.41 (-0.18 %)
$ 30.65
$ 30.93
$ 30.42 x 2,800
$ 30.43 x 3,300
$ 30.01 - $ 31.32
$ 24.48 - $ 35.11
39,753,104
na
174.61B
$ 0.57
nm
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-08-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-08-2023 10-01-2023 10-Q
4 08-09-2023 07-02-2023 10-Q
5 05-10-2023 04-02-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-09-2022 10-02-2022 10-Q
8 08-10-2022 07-03-2022 10-Q
9 05-11-2022 04-03-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-12-2021 10-03-2021 10-Q
12 08-12-2021 07-04-2021 10-Q
13 05-13-2021 04-04-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-27-2020 10-Q
16 08-06-2020 06-28-2020 10-Q
17 05-07-2020 03-29-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 11-07-2019 09-29-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-09-2019 03-31-2019 10-Q
22 02-28-2019 12-31-2018 10-K
23 11-08-2018 09-30-2018 10-Q
24 08-09-2018 07-01-2018 10-Q
25 05-10-2018 04-01-2018 10-Q
26 02-22-2018 12-31-2017 10-K
27 11-09-2017 10-01-2017 10-Q
28 08-10-2017 07-02-2017 10-Q
29 05-11-2017 04-02-2017 10-Q
30 02-23-2017 12-31-2016 10-K
31 11-10-2016 10-02-2016 10-Q
32 08-11-2016 07-03-2016 10-Q
33 05-12-2016 04-03-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-05-2015 09-27-2015 10-Q
36 08-06-2015 06-28-2015 10-Q
37 05-07-2015 03-29-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-06-2014 09-28-2014 10-Q
40 08-07-2014 06-29-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

moderna-stock-trading-lower-on-dismal-guidance-analysts-cuts-price-targets-noting-competitive-pressure-from-gsk-pfizer
Moderna Stock Trading Lower On Dismal Guid...
08/02/2024 18:22:50

Moderna cuts its 2024 sales forecast due to weaker demand for COVID-19 vaccines. Sales now expected between $3B-$3.5B, down fro...

Core News & Articles
Moderna CEO Expects Low EU COVID Sales In ...
08/01/2024 13:00:21

- Conference Call

barclays-maintains-equal-weight-on-pfizer-raises-price-target-to-32
Barclays Maintains Equal-Weight on Pfizer,...
07/31/2024 19:11:40

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $30 to $32.

pfizers-diverse-portfolio-and-strong-execution-earn-analyst-praise-despite-patent-concerns
Pfizer's Diverse Portfolio And Strong Exec...
07/31/2024 18:56:48

Pfizer reported second-quarter adjusted EPS of $0.60, surpassing the consensus of $0.46. Sales reached $13.28 billion, beating ...

pfizers-options-frenzy-what-you-need-to-know
Pfizer's Options Frenzy: What You Need to ...
07/31/2024 16:16:13

wells-fargo-maintains-equal-weight-on-pfizer-raises-price-target-to-30
Wells Fargo Maintains Equal-Weight on Pfiz...
07/31/2024 16:07:48

Wells Fargo analyst Mohit Bansal maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $28 to $30.

cantor-fitzgerald-reiterates-overweight-on-pfizer-maintains-45-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/31/2024 15:39:53

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

ubs-maintains-neutral-on-pfizer-raises-price-target-to-31
UBS Maintains Neutral on Pfizer, Raises Pr...
07/31/2024 15:32:06

UBS analyst Colin Bristow maintains Pfizer (NYSE:PFE) with a Neutral and raises the price target from $30 to $31.

viiv-healthcare-announces-data-demonstrating-2-drug-regimen-dovato-is-as-effective-as-3-drug-regimen-biktarvy-for-maintenance-therapy-of-hiv-1
ViiV Healthcare Announces Data Demonstrati...
07/31/2024 12:24:08

Largest head-to-head randomized clinical trial between DTG/3TC and BIC/FTC/TAF, conducted by SEIMC-GeSIDA Foundation (FSG) show...

bristol-myers-johnson--johnson-abbvie-astrazeneca-expect-minimal-impact-from-upcoming-medicare-price-negotiations
Bristol Myers, Johnson & Johnson, AbbVie, ...
07/30/2024 18:12:15

Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact fro...

tech-stocks-drop-ahead-of-key-earnings-nvidia-falls-crowdstrike-hits-8-month-low-whats-driving-markets-tuesday
Tech Stocks Drop Ahead Of Key Earnings; Nv...
07/30/2024 17:42:51

Investor sentiment took a hit on Tuesday as caution prevailed ahead of significant market events, including key tech earnings r...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
07/30/2024 17:35:22

Core News & Articles
CNBC Halftime Report Final Trades: Bristol...
07/30/2024 17:00:33

stock-of-the-day-pfizer-pattern-offers-lessons-after-better-than-expected-q2-results
Stock Of The Day: Pfizer Pattern Offers Le...
07/30/2024 16:35:55

Like many things on Wall Street, technical analysis is widely misunderstood. Many analysts try to identify chart patterns witho...

pfizer-records-first-sales-growth-in-its-post-covid-era-and-it-owes-it-to-cancer
Pfizer Records First Sales Growth In Its P...
07/30/2024 16:09:06

The market for vaccines and treatments used in managing COVID-19 has shrunk by billions of dollars a year. Forced to rebuild th...

Core News & Articles
Pfizer Exec Says Shares Bristol Myers' Vie...
07/30/2024 15:19:38

- Conf Call

pfizer-exec-says-co-has-significantly-strengthened-its-contracting-position-for-rsv-vaccine-abrysvo-changes-set-to-take-effect-in-august
Pfizer Exec Says Co Has Significantly Stre...
07/30/2024 15:06:29

- Conf Call

pfizer-executive-expects-obesity-pill-dose-data-by-march-2025
Pfizer Executive Expects Obesity Pill Dose...
07/30/2024 15:04:25

- Conference Call

dow-jumps-200-points-pfizer-earnings-top-views
Dow Jumps 200 Points; Pfizer Earnings Top ...
07/30/2024 14:12:54

pfizer-marks-first-revenue-growth-since-covid-revenue-peak-in-2022-lifts-annual-guidance
Pfizer Marks First Revenue Growth Since CO...
07/30/2024 12:56:23

Pfizer reports Q2 adjusted EPS of $0.60, beating the $0.46 consensus. Sales reached $13.28 billion, driven by acquired products...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/02/2024 Humana Inc. (HUM)
08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)